graphic
abstract
highlight
bind
rbd
outsid
bind
interfac
favor
bind
rbd
posit
trimer
neutral
merscov
indirect
rather
direct
competit
summari
major
mechan
antibodymedi
neutral
middl
east
respiratori
syndrom
coronaviru
merscov
involv
competit
cellular
receptor
dipeptidyl
peptidas
bind
receptorbind
domain
rbd
spike
glycoprotein
report
uniqu
epitop
unusu
neutral
mechan
isol
human
antibodi
structur
approach
rbd
outsid
bind
interfac
bind
result
fold
loop
toward
shallow
groov
rbd
interfac
critic
accommod
key
residu
bind
identifi
sitedirect
mutagenesi
structur
model
reveal
bind
rbd
posit
trimer
furthermor
demonstr
synergi
sever
report
antibodi
result
indic
neutral
merscov
indirect
rather
direct
competit
mechan
provid
valuabl
addit
combin
use
antibodi
merscov
infect
data
softwar
avail
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
saudi
arabia
second
major
introduct
highli
pathogen
coronaviru
human
popul
sinc
outbreak
sarscov
china
assiri
et
al
zaki
et
al
global
spread
sarscov
result
infect
nearli
death
worldwid
peiri
et
al
fortun
sarscov
epidem
rapidli
die
convent
public
health
measur
even
exact
mechan
introduct
disappear
human
popul
still
remain
mysteri
graham
et
al
contrast
merscov
epidem
persist
year
sign
abat
http
wwwwho
apart
sudden
initi
outbreak
saudi
arabia
merscov
spread
countri
outsid
arabian
peninsula
carri
infect
travel
bermingham
et
al
lead
outbreak
south
korea
choi
continu
report
human
merscov
infect
affect
region
larg
due
contact
dromedari
camel
believ
major
reservoir
host
merscov
immedi
sourc
human
infect
haagman
et
al
hemida
et
al
compar
sarscov
fatal
rate
approxim
peiri
et
al
merscov
appear
deadli
fatal
rate
reach
high
de
wit
et
al
fact
indic
merscov
remain
sever
longtim
threat
global
health
highlight
urgent
need
effect
prophylact
therapeut
measur
scientif
progress
achiev
sinc
sarscov
epidem
greatli
increas
capac
respond
merscov
like
sarscov
spike
glycoprotein
merscov
play
critic
role
mediat
viral
entri
induc
protect
antibodi
respons
infect
individu
raj
et
al
zumla
et
al
isol
potent
neutral
monoclon
antibodi
report
shortli
identif
merscov
achiev
use
variou
technolog
platform
phage
yeast
display
antibodi
librari
jiang
et
al
tang
et
al
ying
et
al
immun
experiment
anim
chen
et
al
du
et
al
li
et
al
pascal
et
al
wang
et
al
direct
isol
human
survivor
merscov
infect
chen
et
al
corti
et
al
wang
et
al
current
close
differ
neutral
monoclon
antibodi
character
cell
cultur
experiment
anim
model
larg
major
target
receptorbind
domain
rbd
merscov
glycoprotein
interfer
bind
cellular
receptor
dipeptidyl
peptidas
previous
report
isol
two
neutral
antibodi
via
screen
yeastdisplay
librari
human
scfv
singlechain
variabl
domain
fragment
use
merscov
rbd
bait
jiang
et
al
antibodi
demonstr
potent
neutral
activ
live
pseudotyp
merscov
high
level
synergi
use
togeth
structur
determin
antibodi
epitop
specif
provid
critic
foundat
better
understand
mechan
neutral
other
demonstr
merscov
rbd
possess
core
receptorbind
subdomain
chen
et
al
lu
et
al
wang
et
al
wang
et
al
larg
major
neutral
antibodi
merscov
includ
found
target
receptorbind
subdomain
overlap
bind
surfac
chen
et
al
li
et
al
wang
et
al
wang
et
al
ying
et
al
yu
et
al
therefor
antibodi
share
least
one
similar
aspect
neutral
directli
compet
cellular
receptor
bind
rbd
report
structur
function
analysi
previous
isol
potent
neutral
antibodi
variant
reveal
uniqu
epitop
specif
unusu
mechan
action
contrast
report
rbdtarget
neutral
antibodi
compet
bind
rbd
approach
rbd
outsid
bind
interfac
sitedirect
mutagenesi
identifi
sever
key
residu
critic
bind
neutral
activ
structur
comparison
rbd
unbound
antibodybound
state
reveal
signific
conform
chang
rbd
bound
best
knowledg
first
report
demonstr
merscov
neutral
antibodi
indirectli
interfer
bind
conform
chang
uniqu
epitop
specif
unusu
mechan
action
enabl
synerg
antibodi
provid
valuabl
addit
combin
use
antibodi
merscov
infect
overal
structur
variant
bound
rbd
previous
report
human
monoclon
antibodi
target
rbd
spike
glycoprotein
exhibit
strong
neutral
activ
live
pseudotyp
merscov
infect
jiang
et
al
howev
yield
transfect
cell
rather
low
mgl
hamper
effort
toward
detail
structur
analysi
identifi
variant
improv
product
gener
librari
mutant
compris
random
replac
region
display
surfac
yeast
select
bind
rbd
fluorescenceactiv
cell
sort
fac
base
sort
describ
previous
jiang
et
al
among
total
select
mutant
variant
demonstr
substanti
improv
product
maintain
potenc
strong
origin
neutral
pseudotyp
viru
bind
trimer
figur
sequenc
analysi
show
origin
residu
alaglyasnasp
agnd
replac
thrasnthrtyr
tnti
figur
studi
overal
structur
antibodi
bound
rbd
express
cell
obtain
correspond
fab
fragment
antibodi
rbd
complex
form
mix
fab
rbd
howev
despit
repeat
effort
optim
screen
crystal
abl
obtain
xray
diffract
data
rbd
complex
fab
fab
nevertheless
solv
structur
fabrbd
complex
pdb
refin
r
work
r
free
factor
respect
figur
tabl
went
construct
scfv
version
replac
fab
complex
format
rbd
structur
scfv
rbd
complex
pdb
success
solv
resolut
r
work
r
free
factor
respect
figur
tabl
shown
figur
fab
scfv
share
mode
bind
rbd
superimposit
fab
scfv
reveal
respect
recognit
larg
mediat
interact
loop
receptorbind
subdomain
rbd
figur
neglig
structur
differ
found
two
overal
rootmeansquar
deviat
rmsd
align
ca
atom
bind
interfac
loop
rbd
insert
caviti
antibodi
heavi
light
chain
form
interact
cdr
loop
antibodi
except
figur
particular
short
loop
interact
loop
antibodi
heavi
chain
long
loop
predomin
interact
loop
antibodi
light
chain
figur
structur
featur
bind
interfac
rbd
conduct
detail
analysi
structur
featur
bind
interfac
deriv
scfvrbd
complex
figur
bind
interfac
scfv
residu
cdr
except
form
contact
residu
loop
receptorbind
subdomain
rbd
figur
tabl
specif
rbd
residu
loop
interact
heavi
chain
figur
tabl
rbd
residu
loop
interact
antibodi
light
chain
figur
tabl
furthermor
rbd
residu
loop
interact
heavi
chain
well
light
chain
figur
tabl
among
interact
interfac
one
exampl
hydrophob
interact
involv
rbd
loop
heavi
chain
light
chain
light
chain
figur
tabl
exampl
hydrogen
bond
includ
rbd
loop
heavi
chain
rbd
loop
light
chain
rbd
loop
light
chain
rbd
loop
light
chain
figur
tabl
indic
appear
involv
rbd
interact
within
distanc
cutoff
may
explain
unchang
neutral
bind
activ
compar
parent
despit
fourresidu
replac
figur
figur
tabl
previous
shown
interf
interact
solubl
rbd
cellular
receptor
express
surfac
cell
jiang
et
al
surfac
plasmon
reson
spr
analysi
show
bind
solubl
rbd
chipcoupl
reduc
presenc
increas
concentr
dosedepend
manner
figur
howev
structur
superimposit
demonstr
epitop
target
locat
outsid
bind
surfac
rbd
figur
appar
disconnect
prompt
us
compar
avail
rbd
structur
unbound
pdb
chen
et
al
lu
et
al
wang
et
al
pdb
lu
et
al
wang
et
al
state
figur
overal
structur
rbd
remain
rel
stabl
differ
state
rbd
found
conform
chang
loop
figur
particular
chang
involv
fold
loop
toward
shallow
groov
rbd
interfac
critic
accommod
short
helix
figur
maximum
distanc
chang
occur
whose
ca
atom
move
groov
figur
previou
studi
reveal
loop
particip
format
shallow
groov
accommod
dock
short
helix
patch
bind
interfac
figur
residu
loop
found
involv
form
core
hydrophob
peripher
hydrophil
interact
patch
figur
mutat
residu
decreas
bind
affin
rbd
significantli
conform
chang
identifi
therefor
expect
bring
steric
clash
rbd
figur
therebi
prevent
dock
short
helix
shallow
groov
rbd
other
recent
demonstr
merscov
sarscov
trimer
exist
variou
conform
state
involv
posit
rbd
gui
et
al
pallesen
et
al
yuan
et
al
work
hypothesi
three
rbd
posit
keep
trimer
inact
nonreceptorbind
state
wherea
least
one
rbd
posit
requir
trimer
activ
receptorbind
state
pallesen
et
al
yuan
et
al
studi
state
could
bind
access
epitop
superimpos
fabrbd
crystal
structur
onto
merscov
trimer
structur
two
major
conform
state
time
also
analyz
bind
receptor
trimer
glycoprotein
shown
figur
sever
steric
clash
would
expect
fab
ntermin
domain
ntd
neighbor
monom
three
rbd
posit
suggest
epitop
cover
inaccess
inactiv
state
contrast
one
rbd
posit
epitop
becam
readili
expos
access
similarli
receptor
also
favor
rbd
one
posit
pallesen
et
al
yuan
et
al
howev
epitop
readili
access
regardless
state
rbd
taken
togeth
result
indic
bind
rbd
posit
viru
becom
partial
activ
howev
bind
rbd
irrespect
conform
state
within
trimer
confirm
uniqu
epitop
context
bind
neutral
mutat
panel
rbd
residu
alanin
includ
loop
well
loop
mutant
except
could
express
purifi
insect
cell
way
wildtyp
rbd
spr
analysi
show
mutat
rbd
significantli
decreas
bind
affin
figur
figur
mutat
decreas
bind
affin
antibodi
less
figur
next
measur
neutral
activ
pseudotyp
virus
bear
wildtyp
mutant
glycoprotein
cell
entri
assay
consist
bind
chang
pseudotyp
virus
bear
mutat
becam
less
sensit
neutral
figur
bear
mutat
fail
produc
detect
amount
infecti
viral
particl
therefor
exclud
experi
lastli
went
studi
whether
bind
mutant
glycoprotein
also
reduc
protein
express
surfac
cell
specif
transfect
cell
express
either
wildtyp
mutant
glycoprotein
harvest
stain
antibodi
specif
ntd
glycoprotein
control
chen
et
al
analyz
fac
shown
figur
demonstr
variabl
level
reduct
bind
mutant
glycoprotein
control
antibodi
remain
virtual
unchang
furthermor
mutat
complet
abolish
bind
activ
consist
result
obtain
use
pseudotyp
virus
see
also
figur
tabl
result
suggest
reduc
bind
affin
mutant
glycoprotein
one
major
contributor
viral
resist
collect
confirm
uniqu
epitop
target
observ
crystal
structur
highlight
unusu
mechan
neutral
antibodi
epitop
differ
report
antibodi
includ
isol
defin
previous
figur
prompt
us
studi
combin
bind
rbd
gel
filtrat
analysi
show
peak
mixtur
compris
rbd
fab
fab
forward
shift
compar
fab
complex
figur
indic
could
bind
rbd
time
confirm
use
smallangl
xray
scatter
sax
studi
purifi
ternari
complex
solut
initi
built
monomer
model
rbd
ternari
complex
gener
superimpos
crystal
structur
howev
monomer
model
fit
poorli
sax
data
c
valu
figur
investig
assembl
complex
built
dimer
model
ternari
complex
use
interfac
observ
crystal
structur
understand
dynam
assembl
multifox
appli
defin
popul
model
solut
pelikan
et
al
sax
fit
multist
model
monom
model
dimer
model
rbd
significantli
improv
good
fit
c
valu
figur
reveal
transient
complex
fab
transient
behavior
also
observ
secsax
size
exclus
chromatographi
line
sax
figur
broad
distribut
radiu
gyrat
rg
valu
across
secsax
peak
rang
figur
suggest
multist
mixtur
complex
confirm
good
fit
obtain
variou
section
secsax
peak
use
ensembl
model
figur
result
collect
show
capabl
bind
rbd
differ
epitop
form
ternari
complex
previous
shown
exhibit
synergist
effect
titrat
neutral
potenc
equimolar
mixtur
two
antibodi
compar
dose
respons
neutral
assay
perform
individu
antibodi
alon
chou
chou
talalay
keck
et
al
synergi
consist
uniqu
epitop
rbd
figur
test
whether
could
synerg
addit
antibodi
target
either
rbd
ntd
glycoprotein
shown
figur
percent
neutral
obtain
use
combin
demonstr
reduct
half
maxim
inhibitori
concentr
ic
reduct
ic
compar
either
alon
furthermor
combin
index
ci
valu
combin
fraction
effect
valu
effect
dose
ed
ed
ed
ed
respect
ci
valu
indic
addit
effect
indic
synerg
indic
antagon
combin
work
clearli
synergist
manner
furthermor
combin
demonstr
better
synergi
epitop
expos
readili
access
bind
particular
rel
lower
concentr
figur
percent
neutral
combin
demonstr
reduct
ic
reduct
ic
compar
either
antibodi
alon
furthermor
ci
valu
combin
fraction
effect
valu
ed
ed
ed
ed
ed
respect
result
show
act
synergi
rbdspecif
well
ntdspecif
antibodi
report
structur
function
analysi
potent
neutral
antibodi
variant
reveal
uniqu
epitop
specif
novel
mechan
neutral
structur
fab
bound
rbd
determin
resolut
scfv
bound
rbd
solv
demonstr
bind
mode
epitop
specif
contrast
rbdtarget
neutral
antibodi
directli
compet
bind
rbd
approach
rbd
outsid
bind
interfac
target
loop
rbd
demonstr
signific
conform
chang
larg
involv
fold
loop
toward
shallow
groov
rbd
interfac
critic
accommod
short
helix
context
trimer
prefer
bind
rbd
rather
posit
viru
becom
partial
activ
sitedirect
mutagenesi
confirm
key
residu
critic
bind
neutral
activ
reduc
affin
rbd
appear
major
contributor
compromis
neutral
activ
mutant
virus
synergist
effect
observ
rbdspecif
well
ntdspecif
antibodi
although
exact
mechan
remain
unknown
taken
togeth
studi
reveal
recogn
uniqu
neutral
epitop
unusu
mechan
action
special
featur
enabl
synerg
antibodi
provid
valuabl
addit
combin
use
antibodi
merscov
infect
sinc
identif
highli
pathogen
merscov
bermingham
et
al
zaki
et
al
great
effort
made
develop
prophylact
therapeut
intervent
viru
particular
monoclon
antibodi
vaccin
target
glycoprotein
major
research
focu
due
critic
role
mediat
viral
entri
great
potenc
induc
protect
antibodi
respons
infect
naiv
individu
chen
et
al
zumla
et
al
among
close
report
neutral
antibodi
larg
major
shown
directli
compet
cellular
receptor
bind
rbd
chen
et
al
li
et
al
wang
et
al
wang
et
al
ying
et
al
yu
et
al
domin
mechan
action
support
structur
studi
epitop
found
clearli
although
variabl
overlap
bind
surfac
figur
share
mani
biochem
biolog
featur
abovement
antibodi
expect
mechan
neutral
would
follow
suit
howev
novel
epitop
specif
unusu
mechan
action
came
pleasant
surpris
reveal
new
vulner
site
rbd
also
provid
novel
target
futur
vaccin
design
develop
best
knowledg
first
report
demonstr
antibodi
bind
indirectli
disrupt
interact
rbd
exact
process
requir
studi
least
two
possibl
one
antibodi
captur
fix
one
rbd
conform
state
loop
spontan
bend
toward
receptor
bind
interfac
given
highli
dynam
natur
rbd
context
trimer
plausibl
loop
structur
rbd
could
also
quit
flexibl
provid
opportun
antibodi
bind
structur
transform
antibodi
trigger
structur
alter
case
heavi
chain
would
like
push
fold
loop
toward
receptor
bind
interfac
order
achiev
optim
bind
hypothesi
support
atom
analysi
interact
rbd
among
total
interact
bind
residu
loop
interact
light
chain
wherea
loop
particip
bind
heavi
chain
interact
loop
rbd
light
chain
therefor
like
drive
forc
antigenantibodi
bind
howev
optim
bind
would
requir
heavi
chain
overcom
steric
obstruct
push
fold
loop
toward
bind
interfac
result
distort
conform
shown
crystal
structur
regardless
exact
process
observ
fold
loop
toward
bind
interfac
would
expect
disrupt
dock
short
helix
onto
bind
surfac
rbd
therebi
block
viru
entri
note
uniqu
mechan
action
report
virus
antibodi
receptor
bind
site
rb
influenza
viru
bind
site
hiv
type
exert
neutral
activ
larg
direct
competit
respect
receptor
wu
kong
ren
zhou
perhap
closest
scenario
inhibit
found
antibodi
target
region
envelop
bind
may
captur
induc
conform
chang
block
subsequ
interact
region
coreceptor
certainli
hypothesi
would
verifi
futur
barn
et
al
mouquet
et
al
pejchal
et
al
merscov
spike
glycoprotein
show
limit
sequenc
variat
among
differ
strain
especi
rbd
respons
receptor
bind
howev
mean
spike
glycoprotein
remain
unchang
viru
continu
spread
among
multipl
anim
speci
probe
adapt
human
popul
stronger
broader
protect
effect
merscov
combin
use
two
antibodi
provid
superior
altern
wang
et
al
howev
effect
combin
would
requir
candid
antibodi
recogn
distinct
epitop
addit
synergist
effect
uniqu
epitop
therefor
make
good
candid
combin
use
report
elsewher
chen
et
al
li
et
al
wang
et
al
wang
et
al
ying
et
al
yu
et
al
inde
combin
demonstr
impress
synergi
pseudotyp
merscov
assay
exact
mechan
achiev
synergi
howev
uncertain
particularli
share
mechan
disrupt
interact
rbd
presum
two
antibodi
may
preferenti
act
rbd
differ
spatial
tempor
point
interact
receptor
allow
better
exposur
otherwis
less
access
epitop
case
observ
synergi
would
like
deriv
recognit
distinct
epitop
rather
neutral
mechan
obvious
antibodi
distinct
mechan
bind
dispar
epitop
would
like
synergi
share
mechan
overlap
epitop
synergi
show
good
exampl
nevertheless
exact
mechan
underli
synergi
must
complex
treat
differ
case
case
preliminari
result
present
offer
rational
valuabl
addit
combin
use
antibodi
merscov
infect
merscov
rbd
residu
ectodomain
human
residu
express
insect
cell
purifi
rbd
digest
endoglycosidas
room
temperatur
overnight
purifi
gelfiltr
chromatographi
igg
express
cell
purifi
digest
endoproteinas
lysc
c
fab
fc
fragment
separ
load
sampl
onto
diethylaminoethyl
deae
ionexchang
column
gene
encod
scfv
clone
ctermin
histag
heavi
chain
variabl
region
light
chain
variabl
region
vhvl
orient
link
togeth
g
scfv
express
cell
transient
transfect
scfv
captur
nickel
bead
purifi
gelfiltr
chromatographi
crystal
fab
complex
success
grown
c
use
sit
drop
vapor
diffus
method
involv
mix
equal
volum
protein
reservoir
solut
contain
vv
tacsim
ph
sodium
citrat
tribas
dihydr
ph
wv
polyethylen
glycol
sodium
thiocyan
crystal
scfv
complex
success
grown
c
use
sit
drop
vapor
diffus
method
involv
mix
equal
volum
protein
reservoir
solut
contain
tri
ph
wv
polyethylen
glycol
vv
ethylen
glycol
diffract
data
collect
beamlin
shanghai
synchrotron
research
facil
wang
et
al
process
otwinowski
minor
data
collect
process
statist
list
tabl
structur
determin
molecular
replac
crystallograph
softwar
phaser
mccoy
et
al
search
model
merscov
rbd
structur
pdb
structur
variabl
constant
domain
heavi
light
chain
avail
pdb
highest
sequenc
ident
iter
refin
program
phenix
model
build
program
coot
perform
complet
structur
refin
adam
et
al
emsley
cowtan
structur
valid
perform
program
procheck
laskowski
et
al
structur
refin
statist
list
tabl
realtim
bind
analysi
spr
conduct
biacor
instrument
igg
mgml
mgml
mm
sodium
acet
ph
immobil
respons
unit
flow
cell
collect
data
rbd
mutant
inject
buffer
mm
hepe
ph
mm
nacl
vv
tween
flow
cell
variou
concentr
data
analyz
biacor
evalu
softwar
fit
langmuir
bind
model
bind
inhibit
assay
rbd
nm
fab
mix
advanc
molar
ratio
mgml
mm
sodium
acet
ph
immobil
respons
unit
flow
cell
collect
data
merscov
rbd
alon
variou
complex
fab
inject
buffer
mm
hepe
ph
mm
nacl
vv
tween
flow
cell
merscov
pseudotyp
viru
gener
cotransfect
pcdna
express
vector
encod
wildtyp
mutant
merscov
glycoprotein
viral
backbon
plasmid
cell
describ
previous
shang
et
al
viral
titer
pseudotyp
viru
measur
luciferas
activ
rel
light
unit
hr
transfect
mutant
glycoprotein
express
vector
gener
sitedirect
mutagenesi
kit
confirm
sequenc
neutral
assay
perform
incub
tcid
median
tissu
cultur
infecti
dose
pseudotyp
viru
serial
dilut
purifi
antibodi
c
hr
cell
per
well
ad
infect
quantifi
luciferas
activ
hr
infect
ic
calcul
doserespons
inhibit
model
graphpad
prism
graphpad
softwar
cell
surfac
stain
cell
transfect
wildtyp
mutant
merscov
spike
express
plasmid
hr
cell
harvest
wash
use
pb
incub
monoclon
antibodi
mab
min
room
temperatur
cell
wash
stain
fluoresc
label
antihuman
iggp
antimous
iggfitc
secondari
antibodi
cell
wash
pb
analyz
facscalibur
facscomp
softwar
bd
bioscienc
cooper
two
neutral
mab
viru
neutral
synergist
addit
antagonist
interact
viru
neutral
evalu
median
effect
analysi
method
compusyn
softwar
previous
report
measur
neutral
valu
input
program
fraction
effect
fa
rang
two
antibodi
combin
ci
valu
calcul
relat
fa
valu
logarithm
ci
valu
indic
addit
effect
indic
synerg
indic
antagon
sax
data
collect
sibli
beamlin
advanc
light
sourc
lawrenc
berkeley
nation
laboratori
use
wavelength
pilatu
detector
sampletodetector
distanc
classen
et
al
result
scatter
vector
rang
scatter
vector
defin
q
sinql
scatter
angl
sec
line
secsax
perform
ensur
aggregationfre
state
sampl
sec
column
equilibr
run
buffer
mm
trishcl
ph
mm
nacl
glycerol
sodium
azid
flow
rate
mlmin
sampl
run
sec
xray
exposur
collect
continu
elut
sax
frame
record
prior
protein
elut
peak
use
subtract
frame
subtract
frame
investig
r
g
scatter
intens
q
deriv
guinier
approxim
q
exp
r
g
limit
qr
g
guinier
fournet
r
g
valu
compar
collect
sax
curv
across
entir
elut
peak
elut
peak
map
plot
scatter
intens
q
rel
record
frame
graduat
decreas
r
g
valu
across
elut
peak
indic
transient
sampl
behavior
sax
also
acquir
highthroughput
modal
sampl
concentr
mgml
compar
secsax
profil
full
atom
model
built
program
model
construct
miss
loop
linker
sali
blundel
theoret
sax
profil
correspond
fit
experiment
data
calcul
use
program
fox
schneidmanduhovni
et
al
multist
model
complex
coexist
solut
select
multifox
schneidmanduhovni
et
al
size
multist
model
select
base
level
improv
sax
fit
access
number
atom
coordin
report
paper
pdb
supplement
inform
includ
seven
figur
two
tabl
found
articl
onlin
http
